Clinical Trial 45639

Miami, FL 33126


Summary:

Study  phase 3 trial evaluating the antiviral drug  as potential therapy for mild to moderate COVID-19 in adult outpatients  who are not requiring hospitalization,  who had a positive COVID-19 test within 72 hours of study enrollment. 


Study subjects should meet all of the following criteria:
1. Adults age 18 or older
2. Tested positive for SARS-CoV-2 by RT-PCR assay (first positive test) collected within 72 hours of randomization.
3. Stated willingness to give their written informed consent to participate in the study.

4.Females must be unable to bear children, OR ensure that their male partner is incapable of fathering a child, OR, if of childbearing potential will strictly adhere to contraceptive measures during the study and for seven days following the last dose of study medication (as detailed in section 5.8)
5. Females must agree to stop breast-feeding prior to first dose of study drug and through seven days after completing therapy
6. Females must have a negative pregnancy test at screening
7. Ability to take oral medication and be willing to adhere the pills.


Qualified Participants May Receive:

Participant  will received treatment for Covid 19 for prevention in the progression of the virus and may improve faster .

Participant will received a tablet  wich is easier to take at home and can reduce the load of healthcare workers. 

Participant will receive a compesation for travel and expenses.

 


Available At:

Quality Professional Healthcare, Corp
5040 Nw 7 St Suite 632
Miami, FL 33126
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.